Tregs and transplantation tolerance.

PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs. J Clin Invest (2006) 1.93

An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest (2004) 1.69

CD39 and control of cellular immune responses. Purinergic Signal (2007) 1.68

Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy. Am J Transplant (2013) 1.60

Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection. Am J Transplant (2009) 1.59

CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. J Mol Cell Biol (2011) 1.45

Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia. Blood (2009) 1.35

Sodium benzoate, a food additive and a metabolite of cinnamon, modifies T cells at multiple steps and inhibits adoptive transfer of experimental allergic encephalomyelitis. J Immunol (2007) 1.26

Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice. Blood (2014) 1.20

Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation. Am J Transplant (2013) 1.14

Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. J Clin Invest (2006) 1.13

Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. J Immunol (2009) 1.12

Human dendritic cell subsets for vaccination. J Clin Immunol (2005) 1.09

Systemic targeting of CpG-ODN to the tumor microenvironment with anti-neu-CpG hybrid molecule and T regulatory cell depletion induces memory responses in BALB-neuT tolerant mice. Cancer Res (2008) 1.06

CD8+ Tregs in lupus, autoimmunity, and beyond. Autoimmun Rev (2010) 1.04

CD40-activated B cells are more potent than immature dendritic cells to induce and expand CD4(+) regulatory T cells. Cell Mol Immunol (2010) 1.04

Central memory CD8+ T lymphocytes mediate lung allograft acceptance. J Clin Invest (2014) 0.99

Evidence that FoxP3+ regulatory T cells may play a role in promoting long-term acceptance of composite tissue allotransplants. Transplantation (2011) 0.96

CD46-induced human Treg enhance B-cell responses. Eur J Immunol (2009) 0.94

TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection. Immunotherapy (2010) 0.92

Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation. PLoS One (2011) 0.91

CCL-21 conditioned regulatory T cells induce allotolerance through enhanced homing to lymphoid tissue. J Immunol (2013) 0.90

Activation of counter-regulatory mechanisms in a rat renal acute rejection model. BMC Genomics (2008) 0.89

Cloning of feline FOXP3 and detection of expression in CD4+CD25+ regulatory T cells. Vet Immunol Immunopathol (2007) 0.89

Leukocyte homing, fate, and function are controlled by retinoic acid. Physiol Rev (2015) 0.88

Inhibiting CXCR3-dependent CD8+ T cell trafficking enhances tolerance induction in a mouse model of lung rejection. J Immunol (2011) 0.87

Inflammation and transplantation tolerance. Semin Immunopathol (2011) 0.87

TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection. J Immunol (2009) 0.82

CD154 blockade abrogates allospecific responses and enhances CD4(+) regulatory T-cells in mouse orthotopic lung transplant. Am J Transplant (2011) 0.81

Tolerance-inducing strategies in islet transplantation. Int J Endocrinol (2012) 0.80

Low-intensity transplant regimens facilitate recruitment of donor-specific regulatory T cells that promote hematopoietic engraftment. Proc Natl Acad Sci U S A (2007) 0.80

Reduced levels of both circulating CD4+ CD25+ CD127(low/neg) and CD4+ CD8(neg) invariant natural killer regulatory T cells in stable heart transplant recipients. Clin Exp Immunol (2010) 0.79

CD4+CD25highCD127low regulatory T cells in peripheral blood are not an independent factor for chronic graft-versus-host disease after allogeneic stem cell transplantation. ScientificWorldJournal (2012) 0.79

The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection. Clinics (Sao Paulo) (2012) 0.79

Amelioration of ovalbumin-induced allergic airway disease following Der p 1 peptide immunotherapy is not associated with induction of IL-35. Mucosal Immunol (2013) 0.79

Intermittent antibody-based combination therapy removes alloantibodies and achieves indefinite heart transplant survival in presensitized recipients. Transplantation (2010) 0.78

Ex vivo-expanded cynomolgus macaque regulatory T cells are resistant to alemtuzumab-mediated cytotoxicity. Am J Transplant (2013) 0.78

B7-H4 Pathway in Islet Transplantation and β-Cell Replacement Therapies. J Transplant (2011) 0.78

A novel differentiation pathway from CD4(+) T cells to CD4(-) T cells for maintaining immune system homeostasis. Cell Death Dis (2016) 0.76

Improving the safety of tolerance induction: chimerism and cellular co-treatment strategies applied to vascularized composite allografts. Clin Dev Immunol (2012) 0.75

The Induction and Maintenance of Transplant Tolerance Engages Both Regulatory and Anergic CD4(+) T cells. Front Immunol (2017) 0.75

Differential sensitivity of regulatory and effector T cells to cell death: a prerequisite for transplant tolerance. Front Immunol (2015) 0.75

T regulatory cell mediated immunotherapy for solid organ transplantation: A clinical perspective. Mol Med (2016) 0.75

The function of regulatory T cells at the ocular surface: Review. Ocul Surf (2017) 0.75

Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 40.32

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol (2003) 38.57

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol (1995) 29.42

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med (2003) 26.05

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 16.28

Tolerogenic dendritic cells. Annu Rev Immunol (2001) 13.77

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med (2000) 13.13

Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol (2001) 12.00

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol (1998) 11.26

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol (2002) 9.18

Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol (1999) 8.98

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science (1994) 8.69

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature (1996) 6.61

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med (2000) 6.45

Regulatory T cells in transplantation tolerance. Nat Rev Immunol (2003) 6.42

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med (2002) 6.11

Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med (2000) 5.07

"Infectious" transplantation tolerance. Science (1993) 4.98

CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med (2002) 4.56

Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med (2002) 4.37

Identification of regulatory T cells in tolerated allografts. J Exp Med (2002) 3.60

CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med (2001) 3.51

Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J Exp Med (2002) 3.31

Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity (2003) 3.28

IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol (2001) 3.22

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med (1999) 3.17

Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med (2002) 3.02

Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol (2001) 2.93

Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity (2003) 2.80

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med (1999) 2.74

Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells. J Autoimmun (2001) 2.49

Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol (2000) 2.24

Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med (2000) 2.04

Mixed chimerism and transplant tolerance. Immunity (2001) 1.97

The regulatory T cell family: distinct subsets and their interrelations. J Immunol (2003) 1.92

Regulating the immune response to transplants. a role for CD4+ regulatory cells? Immunity (2001) 1.90

Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance. J Immunol (2002) 1.85

The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery. J Clin Invest (2003) 1.75

Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process. J Immunol (2004) 1.59

Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J Immunol (2000) 1.55

T cell death and transplantation tolerance. Immunity (2001) 1.51

CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression. J Immunol (1999) 1.50

The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol (2003) 1.50

Suppressor T cells in mice made unresponsive to skin allografts. Nature (1975) 1.49

Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci U S A (2001) 1.48

T cell suppression in transplantation tolerance through linked recognition. J Immunol (1996) 1.45

Infectious tolerance. Curr Opin Immunol (1998) 1.39

Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation (1996) 1.39

Allorecognition. Am J Transplant (2001) 1.30

Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J Immunol (2003) 1.24

Regulatory T cells and organ transplantation. Semin Immunol (2004) 1.22

Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. J Exp Med (1985) 1.21

Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade. J Immunol (2001) 1.14

A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance. J Clin Invest (1998) 1.13

Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc Natl Acad Sci U S A (1992) 1.10

Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol (1994) 1.09

Exploiting tolerance processes in transplantation. Science (2004) 1.02

Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells. Transplantation (2004) 1.00

Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Transplantation (1993) 0.96

Routes to transplant tolerance versus rejection; the role of cytokines. Immunity (2004) 0.95

Oral exposure to alloantigen generates intragraft CD8+ regulatory cells. J Immunol (2001) 0.91

Human CD(4+)CD(25+) regulatory T cells and infectious tolerance. Transplantation (2004) 0.91

CD4-positive suppressor cells block allotransplant rejection. J Immunol (1995) 0.85

Mixed hematopoietic chimerism and transplantation tolerance. Immunol Res (1997) 0.83

Thymus requirement and antigen dependency in the "infectious" tolerance pathway in transplant recipients. J Immunol (1998) 0.80

Apoptosis and transplantation tolerance. Immunol Rev (2003) 0.79

Oral antigen induces allograft survival by linked suppression via the indirect pathway. Transplant Proc (2001) 0.79

Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med (2007) 6.61

Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol (2007) 5.99

Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med (2003) 4.12

Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest (2010) 3.59

Toll-like receptor ligands directly promote activated CD4+ T cell survival. J Immunol (2004) 2.79

Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J Immunol (2004) 2.54

The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology. Immunity (2012) 2.52

Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J Immunol (2003) 2.47

TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis. Nat Med (2006) 2.44

TRAF6 is a critical factor for dendritic cell maturation and development. Immunity (2003) 2.36

Organ transplantation--how much of the promise has been realized? Nat Med (2005) 2.26

A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin. J Invest Dermatol (2012) 2.05

The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation. Immunity (2006) 2.04

Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function. Diabetes (2012) 2.02

Notch signaling augments T cell responsiveness by enhancing CD25 expression. J Immunol (2003) 1.95

Migratory and lymphoid-resident dendritic cells cooperate to efficiently prime naive CD4 T cells. Immunity (2008) 1.95

PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs. J Clin Invest (2006) 1.93

The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity (2002) 1.89

Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat Med (2002) 1.84

Allograft rejection mediated by memory T cells is resistant to regulation. Proc Natl Acad Sci U S A (2007) 1.81

CTLA4Ig: bridging the basic immunology with clinical application. Immunity (2006) 1.75

Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J Immunol (2005) 1.61

Impaired T cell function in RANTES-deficient mice. Clin Immunol (2002) 1.60

Organ transplantation: halfway through the first century. J Am Soc Nephrol (2004) 1.59

Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J Immunol (2005) 1.58

Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J Clin Invest (2014) 1.58

T cell repertoire following autologous stem cell transplantation for multiple sclerosis. J Clin Invest (2014) 1.53

High-sensitivity detection and quantitative analysis of native protein-protein interactions and multiprotein complexes by flow cytometry. Sci STKE (2007) 1.51

Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol (2006) 1.51

The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model. J Clin Invest (2008) 1.50

The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol (2003) 1.50

Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes. Mol Cell Biol (2004) 1.48

An obligate cell-intrinsic function for CD28 in Tregs. J Clin Invest (2013) 1.46

MyD88 plays a critical T cell-intrinsic role in supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus infection. J Immunol (2008) 1.45

T cell expression of MyD88 is required for resistance to Toxoplasma gondii. Proc Natl Acad Sci U S A (2008) 1.43

Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J Immunol (2006) 1.42

Mechanisms underlying blockade of allograft acceptance by TLR ligands. J Immunol (2008) 1.41

Hypoxia inducible factor 1 alpha regulates T cell receptor signal transduction. Proc Natl Acad Sci U S A (2005) 1.38

Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ regulatory T cells. J Immunol (2006) 1.37

Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN. J Immunol (2006) 1.37

An update on regulatory T cells in transplant tolerance and rejection. Nat Rev Nephrol (2010) 1.35

Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA (2012) 1.33

Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+ CD25+ T cells. J Immunol (2005) 1.32

CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells. Immunol Lett (2007) 1.29

Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells. Infect Immun (2007) 1.26

Allograft rejection in a new allospecific CD4+ TCR transgenic mouse. Am J Transplant (2003) 1.21

Specificity of CD4+CD25+ regulatory T cell function in alloimmunity. J Immunol (2006) 1.19

Heterologous immunity and homeostatic proliferation as barriers to tolerance. Curr Opin Immunol (2004) 1.19

Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice. J Clin Invest (2010) 1.17

A role for IL-27 in limiting T regulatory cell populations. J Immunol (2011) 1.17

Regulation of T-cell responses by PTEN. Immunol Rev (2008) 1.15

Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs. J Clin Invest (2012) 1.15

The innate immune system in allograft rejection and tolerance. J Immunol (2007) 1.13

Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. J Clin Invest (2002) 1.12

Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection. J Immunol (2004) 1.10

Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation. J Exp Med (2002) 1.07

New insights on OX40 in the control of T cell immunity and immune tolerance in vivo. J Immunol (2011) 1.06

Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells. Proc Natl Acad Sci U S A (2009) 1.06

The proliferative capacity of individual naive CD4(+) T cells is amplified by prolonged T cell antigen receptor triggering. J Exp Med (2002) 1.05

Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. J Autoimmun (2004) 1.04

Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes. J Immunol Methods (2012) 1.04

The Immune Tolerance Network at 10 years: tolerance research at the bedside. Nat Rev Immunol (2010) 1.03

TNF receptor-associated factor 6 deficiency during hemopoiesis induces Th2-polarized inflammatory disease. J Immunol (2003) 1.03

TRAF6 inhibits Th17 differentiation and TGF-beta-mediated suppression of IL-2. Blood (2010) 1.01

The physician's voice in the health care debate. J Clin Invest (2009) 1.01

Dendritic cell expression of the signaling molecule TRAF6 is critical for gut microbiota-dependent immune tolerance. Immunity (2013) 1.00

MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling. Proc Natl Acad Sci U S A (2013) 0.97

Regulation of T cell homeostasis and responses by pten. Front Immunol (2012) 0.97

New TCR transgenic model for tracking allospecific CD4 T-cell activation and tolerance in vivo. Am J Transplant (2003) 0.97

Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion. J Immunol (2002) 0.97

Antiviral memory CD8 T-cell differentiation, maintenance, and secondary expansion occur independently of MyD88. Blood (2011) 0.96

Signals and pathways controlling regulatory T cells. Immunol Rev (2014) 0.95

Surface T-cell antigen receptor expression and availability for long-term antigenic signaling. Immunol Rev (2003) 0.95

Routes to transplant tolerance versus rejection; the role of cytokines. Immunity (2004) 0.95

Cutting edge: requirement for TRAF6 in the induction of T cell anergy. J Immunol (2008) 0.95

A role for regulatory T cells in cutaneous T-Cell lymphoma; induction of a CD4 + CD25 + Foxp3+ T-cell phenotype associated with HTLV-1 infection. J Invest Dermatol (2006) 0.95

Animal house. J Clin Invest (2008) 0.94

The contribution of direct TLR signaling to T cell responses. Immunol Res (2009) 0.94

A novel clinically relevant approach to tip the balance toward regulation in stringent transplant model. Transplantation (2010) 0.94

Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: implications for peripheral B and T cell responsiveness. J Immunol (2003) 0.93

Adeno-associated virus-mediated CTLA4Ig gene transfer protects MHC-mismatched renal allografts from chronic rejection. J Am Soc Nephrol (2006) 0.93

Homeostatic T cell proliferation as a barrier to T cell tolerance. Philos Trans R Soc Lond B Biol Sci (2005) 0.91

Physical and functional bivalency observed among TCR/CD3 complexes isolated from primary T cells. J Immunol (2011) 0.90

Mechanism of T cell-mediated endothelial apoptosis. Transplantation (2002) 0.89

After further review. J Clin Invest (2009) 0.89

Tolerance: one transplant for life. Transplantation (2014) 0.89

Mechanisms of tolerance induced by donor-specific transfusion and ICOS-B7h blockade in a model of CD4+ T-cell-mediated allograft rejection. Am J Transplant (2005) 0.89

Constitutive activation of STAT5 supersedes the requirement for cytokine and TCR engagement of CD4+ T cells in steady-state homeostasis. J Immunol (2006) 0.88

Innate immunity in transplant tolerance and rejection. Immunol Rev (2011) 0.88

Site-specific accumulation of recently activated CD4+ Foxp3+ regulatory T cells following adoptive transfer. Eur J Immunol (2012) 0.87

Marking a path to transplant tolerance. J Clin Invest (2008) 0.85

Lymphocyte depletion as a barrier to immunological tolerance. Contrib Nephrol (2005) 0.85

EGR-2 is not required for in vivo CD4 T cell mediated immune responses. PLoS One (2010) 0.85

Interruption of dendritic cell-mediated TIM-4 signaling induces regulatory T cells and promotes skin allograft survival. J Immunol (2013) 0.84

Regulation of T cell activation and tolerance by phospholipase C gamma-1-dependent integrin avidity modulation. J Immunol (2003) 0.83